483 GlaxoSmithKline Jun 2006

483 GlaxoSmithKline Jun 2006

Thomas Berry FDA, Sarah Holliday FDA$119.00 - Available Now

FDA investigators audited the GlaxoSmithKline - Zebulon, NC, United States facility and issued inspectional observations (via FDA 483) on 16 Jun 2006.

Product details

  • Category: Human Drugs
  • Inspection end: 16 Jun 2006
  • Location: Zebulon, United States
  • FEI: 1033964
Add To Cart